Masanao Akiyama

Phase I and Pharmacokinetic Study of Inotuzumab Ozogamicin (CMC- 544) as a Single Agent in Japanese Patients with Follicular Lymphoma Pretreated with Rituximab.

M. Ogura, K. Tobinai, T. Uchida, 2008 .